Equities research analysts expect that Orthofix International NV (NASDAQ:OFIX) will announce $107.65 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Orthofix International’s earnings, with estimates ranging from $106.90 million to $108.40 million. Orthofix International posted sales of $102.74 million during the same quarter last year, which suggests a positive year-over-year growth rate of 4.8%. The business is scheduled to issue its next quarterly earnings results on Thursday, May 3rd.
According to Zacks, analysts expect that Orthofix International will report full-year sales of $107.65 million for the current financial year, with estimates ranging from $453.50 million to $460.00 million. For the next fiscal year, analysts expect that the business will report sales of $479.53 million per share, with estimates ranging from $474.00 million to $490.00 million. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Orthofix International.
Orthofix International (NASDAQ:OFIX) last issued its quarterly earnings data on Monday, February 26th. The medical device company reported $0.52 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.02. The company had revenue of $116.90 million for the quarter, compared to analyst estimates of $116.93 million. Orthofix International had a net margin of 1.43% and a return on equity of 10.66%. Orthofix International’s revenue was up 7.7% compared to the same quarter last year. During the same period last year, the company posted $0.42 earnings per share.
Several research firms have issued reports on OFIX. Gabelli reaffirmed a “buy” rating on shares of Orthofix International in a report on Wednesday, February 28th. BidaskClub raised shares of Orthofix International from a “sell” rating to a “hold” rating in a report on Saturday, February 3rd. TheStreet raised shares of Orthofix International from a “c+” rating to a “b” rating in a report on Tuesday, March 20th. SunTrust Banks boosted their price objective on shares of Orthofix International to $67.00 and gave the company a “buy” rating in a report on Monday, March 5th. Finally, ValuEngine raised shares of Orthofix International from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. One analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. Orthofix International has an average rating of “Buy” and an average target price of $57.42.
OFIX stock traded down $0.26 during trading on Tuesday, hitting $58.55. 11,585 shares of the company’s stock traded hands, compared to its average volume of 135,326. The firm has a market cap of $1,088.29, a price-to-earnings ratio of 36.30, a PEG ratio of 3.32 and a beta of 0.24. Orthofix International has a 1 year low of $36.10 and a 1 year high of $61.00.
Institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. lifted its position in Orthofix International by 8.5% during the fourth quarter. BlackRock Inc. now owns 2,464,012 shares of the medical device company’s stock valued at $134,781,000 after purchasing an additional 192,830 shares during the period. Dimensional Fund Advisors LP lifted its position in Orthofix International by 1.2% during the third quarter. Dimensional Fund Advisors LP now owns 880,901 shares of the medical device company’s stock valued at $41,623,000 after purchasing an additional 10,781 shares during the period. Millennium Management LLC lifted its position in Orthofix International by 25.6% during the fourth quarter. Millennium Management LLC now owns 651,969 shares of the medical device company’s stock valued at $35,663,000 after purchasing an additional 132,743 shares during the period. Renaissance Technologies LLC raised its position in shares of Orthofix International by 29.4% in the fourth quarter. Renaissance Technologies LLC now owns 558,679 shares of the medical device company’s stock worth $30,560,000 after acquiring an additional 126,979 shares during the period. Finally, Teachers Advisors LLC raised its position in shares of Orthofix International by 1.9% in the fourth quarter. Teachers Advisors LLC now owns 327,421 shares of the medical device company’s stock worth $17,910,000 after acquiring an additional 6,117 shares during the period. 94.74% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: This news story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/06/107-65-million-in-sales-expected-for-orthofix-international-nv-ofix-this-quarter.html.
About Orthofix International
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Get a free copy of the Zacks research report on Orthofix International (OFIX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.